The utility of amyloid (and tau) biomarkers in the era of disease modifying treatments in Alzheimer’s diseaseDementia with Lewy bodies: new developments in diagnosis and management. – Nicolai Franzmeier

Existing Users Log InUsername or EmailPassword Remember Me   0

Dementia with Lewy bodies: new developments in diagnosis and management. – DLB Prof. Dr. Dag Aarsland

Existing Users Log InUsername or EmailPassword Remember Me   0

The utility of amyloid (and tau) biomarkers in the era of disease modifying treatments in Alzheimer’s diseaseDementia with Lewy bodies: new developments in diagnosis and management. – Nicolai Franzmeier

Existing Users Log InUsername or EmailPassword Remember Me   0

Dementia with Lewy bodies: new developments in diagnosis and management. – DLB Prof. Dr. Dag Aarsland

Existing Users Log InUsername or EmailPassword Remember Me   0

Wenn es nicht M. parkinson ist… Progressive supranukleäre Blickparese – PSP Prof. Dr. Höglinger

Existing Users Log InUsername or EmailPassword Remember Me   0